Filtered By:
Source: Medscape Medical News Headlines
Condition: Bleeding
This page shows you your search results in order of date.
Order by Relevance | Date
Total 13 results found since Jan 2013.
Tendyne Transcatheter Mitral Valve Shows Sustained Benefits at 2 Years Tendyne Transcatheter Mitral Valve Shows Sustained Benefits at 2 Years
More than 93% of patients had no mitral regurgitation at 2 years, but concerns were raised about rates of major bleeding and disabling stroke.Medscape Medical News
Source: Medscape Medical News Headlines - July 30, 2020 Category: Consumer Health News Tags: Cardiology News Source Type: news
Dual Antiplatelet Therapy With Cilostazol Cuts Recurrent Stroke Dual Antiplatelet Therapy With Cilostazol Cuts Recurrent Stroke
New results show cilostazol plus aspirin or clopidogrel reduced recurrent stroke rate by half over aspirin or clopidogrel alone in high-risk stroke patients without increased bleeding.Medscape Medical News
Source: Medscape Medical News Headlines - February 7, 2019 Category: Consumer Health News Tags: Neurology & Neurosurgery News Source Type: news
RE-LY: NSAIDs Plus Anticoagulants a Dangerous Combination RE-LY: NSAIDs Plus Anticoagulants a Dangerous Combination
The authors caution against using an NSAID with oral anticoagulants in patients with atrial fibrillation after finding an increased risk for bleeding and stroke.Medscape Medical News
Source: Medscape Medical News Headlines - July 11, 2018 Category: Consumer Health News Tags: Cardiology News Source Type: news
Rivaroxaban Not Superior to Aspirin for Recurrent Stroke After ESUS Rivaroxaban Not Superior to Aspirin for Recurrent Stroke After ESUS
Researchers were ' surprised and disappointed ' to report rivaroxaban did not prevent recurrent stroke after first embolic stroke of undetermined source better than did aspirin but rather increased major bleeding.Medscape Medical News
Source: Medscape Medical News Headlines - May 16, 2018 Category: Consumer Health News Tags: Neurology & Neurosurgery News Source Type: news
Rivaroxaban Plus Aspirin Cuts Stroke Rate in Half Rivaroxaban Plus Aspirin Cuts Stroke Rate in Half
New results from the COMPASS trial show combination therapy reduced the ischemic stroke rate by 49% vs aspirin alone in patients with stable vascular disease, without increasing intracerebral bleeding.Medscape Medical News
Source: Medscape Medical News Headlines - January 31, 2018 Category: Consumer Health News Tags: Neurology & Neurosurgery News Source Type: news
Real-world Study Reassures on Dabigatran Stroke, ICH Rates Real-world Study Reassures on Dabigatran Stroke, ICH Rates
But results confirm gastrointestinal bleeding risk, particularly in the elderly and those with renal failure, and questions over the MI risk still remain.Medscape Medical News
Source: Medscape Medical News Headlines - November 29, 2017 Category: Consumer Health News Tags: Neurology & Neurosurgery News Source Type: news
Oct 20 Cardiology News Oct 20 Cardiology News
Secondary AF, Heart failure statistics, DOAC bleeding rates, uncontrolled hypertension and stroke risk factors are discussed by John Mandrola in this week ' s podcast.theheart.org on Medscape
Source: Medscape Medical News Headlines - October 20, 2017 Category: Consumer Health News Tags: Cardiology News Source Type: news
New Tool Predicts Bleeding Risk After TIA, Ischemic Stroke New Tool Predicts Bleeding Risk After TIA, Ischemic Stroke
The S2TOP-BLEED score can be used in clinical practice to identify patients receiving antiplatelet therapy who are at high risk for major bleeding after transient ischemic attack or ischemic stroke.Medscape Medical News
Source: Medscape Medical News Headlines - August 15, 2017 Category: Consumer Health News Tags: Neurology & Neurosurgery News Source Type: news
ABO Blood Type Linked to Mortality, Stroke Risk Post-LVAD ImplantABO Blood Type Linked to Mortality, Stroke Risk Post-LVAD Implant
The AB blood type group showed significant outcome differences vs other ABO groups, but the real surprise came when examining O vs non-O types for bleeding events, with results opposite the hypothesis. Heartwire from Medscape
Source: Medscape Medical News Headlines - April 28, 2016 Category: Consumer Health News Tags: Cardiology News Source Type: news
PCPs Often Misestimate Stroke and Bleeding Risk in AFPCPs Often Misestimate Stroke and Bleeding Risk in AF
A new study indicated that PCPs often under- or overestimate stroke and bleeding risk in patients with atrial fibrillation and that oral anticoagulant dosages are often suboptimal. Medscape Medical News
Source: Medscape Medical News Headlines - October 27, 2015 Category: Consumer Health News Tags: Internal Medicine News Source Type: news
Early-Phase NOAC, VKA Therapy: Similar Bleeding, Stroke Risk Early-Phase NOAC, VKA Therapy: Similar Bleeding, Stroke Risk
Thus, physicians must be just as cautious when initiating dabigatran or rivaroxaban as when initiating a vitamin-K agonist, the authors of this French nationwide cohort study say. Heartwire from Medscape
Source: Medscape Medical News Headlines - August 6, 2015 Category: Consumer Health News Tags: Cardiology News Source Type: news
Clinical Outcomes Not Valued Equally With NOACs, WarfarinClinical Outcomes Not Valued Equally With NOACs, Warfarin
Patients with cardiovascular disease were willing to accept a higher risk of stroke and MI to avoid fatal bleeding, while those who previously had had an MI or stroke placed a greater weight on avoiding these risks in the future. Heartwire
Source: Medscape Medical News Headlines - November 13, 2014 Category: Consumer Health News Tags: Cardiology News Source Type: news
CHANCE: Short-Term Antiplatelet Combo Beneficial Post StrokeCHANCE: Short-Term Antiplatelet Combo Beneficial Post Stroke
This trial has succeeded where others have failed, possibly because it excluded patients at high risk of bleeding and because dual therapy was started early and continued for only 3 weeks. Medscape Medical News
Source: Medscape Medical News Headlines - July 3, 2013 Category: Consumer Health News Tags: Neurology & Neurosurgery News Source Type: news
